Birgitta Sander

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elı́as Campo, Elaine S. Jaffe, James R. Cook et al. · Blood · 2022 · 1.4K citations · Full text

Immunology, Pathology, International Consensus Classification +22

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy

Lena von Bahr, Berit Sundberg, Lena Lönnies et al. · Biology of Blood and Marrow Transplantation · 2011 · 311 citations · Full text

Cell Therapy, Immunology, Pathology +20

Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium

Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2007 · 304 citations · Full text

Molecular Subsets of Mantle Cell Lymphoma Defined by the <i>IGHV</i> Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features

Alba Navarro, Guillem Clot, Cristina Royo et al. · Cancer Research · 2012 · 249 citations · Full text

Sox11 Expression, Immunology, Pathology +16

Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

Andreas Rosenwald, Susanne Bens, Ranjana H. Advani et al. · Journal of Clinical Oncology · 2019 · 244 citations · Full text